Pan-Canadian Pharmaceutical Alliance negotiations 2014-2018
Author: Nigel SB Rawson, Ph.D.
Created in 2010, the pan-Canadian Pharmaceutical Alliance (pCPA) is the federal, provincial and territorial governments’ organization that negotiates prices of new and existing medicines with pharmaceutical manufacturers. The pCPA is another hurdle beyond that of the health technology assessment (HTA) process for Canadian patients with unmet needs waiting to access new drugs. This study investigates the reliability of the pCPA negotiation reports published between 2014 and 2018, the time taken for negotiations, and whether the decision to negotiate and the success of negotiations were associated with the outcome of related HTAs by the Canadian Agency for Drugs and Technologies in Health (CADTH).